Corticosteroid Prophylaxis on the Cardiopulmonary Bypass-Induced Systemic Inflammatory Response

NCT01296074 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Heart Valve Diseases
Systemic Inflammatory Response Syndrome

Interventions

DRUG: Corticosteroid

Sponsor

Beijing Anzhen Hospital

Collaborators

[object Object]